Inhibitors of the Ras Signal Transduction Pathway as Potential Antitumour Agentsx
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition
- Vol. 11 (2) , 77-95
- https://doi.org/10.3109/14756369609036536
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Inhibition of cell growth of human hepatoma cell line (HepG2) by a farnesyl protein transferase inhibitor: A preferential suppression of ras farnesylationInternational Journal of Cancer, 1996
- Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression.The Journal of cell biology, 1995
- Review Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylation: A new approach to cancer chemotherapyExpert Opinion on Therapeutic Patents, 1995
- Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans.Proceedings of the National Academy of Sciences, 1995
- Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein: Farnesyltransferase to different extentsBiochemical Pharmacology, 1995
- Mad Bet for RabNature, 1993
- Identification of Ras farnesyltransferase inhibitors by microbial screening.Proceedings of the National Academy of Sciences, 1993
- Posttranslational modification of proteins by isoprenoids in mammalian cellsThe FASEB Journal, 1990
- Common Modifications of Trimeric G Proteins and ras Protein: Involvement of PolyisoprenylationScience, 1990
- ras GENESAnnual Review of Biochemistry, 1987